Get the Stockscreener App
1.06
1.92%
0.02
Pre-market:
1.06
Vivani Medical Inc stock is traded at $1.06, with a volume of 187.69K.
It is up +1.92% in the last 24 hours and down -7.83% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
See More
Previous Close:
$1.04
Open:
$1.1
24h Volume:
187.69K
Relative Volume:
1.85
Market Cap:
$62.79M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.1633
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
-2.75%
1M Performance:
-7.83%
6M Performance:
-17.83%
1Y Performance:
-45.08%
1-Day Range:
$1.0301
$1.10
1-Week Range:
$1.0296
$1.10
52-Week Range:
$1.0296
$2.22
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.06 | 62.79M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical advances GLP-1 implant in clinical trial By Investing.com - Investing.com Australia
Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial - Yahoo Finance
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults - BioSpace
H.C. Wainwright maintains Buy on Vivani stock, target at $3 By Investing.com - Investing.com South Africa
Vivani Medical Completes Enrollment, Begins Dosing in Diabetes Implant Trial -March 13, 2025 at 08:28 am EDT - Marketscreener.com
Vivani Medical advances GLP-1 implant in clinical trial - Investing.com India
Vivani Medical Advances with LIBERATE-1 Clinical Trial - TipRanks
EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity - Benzinga
Vivani to spin off Cortigent as an independent entity By Investing.com - Investing.com Australia
Vivani looking to get slim with Cortigent neurostimulation spin - BioWorld Online
Vivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq Listing - Yahoo Finance
Vivani Medical to spin-off neurostim business Cortigent as public company - Yahoo
Vivani looking to slim with Cortigent neurostimulation spin - BioWorld Online
Vivani Medical intends to spin off brain implants division -March 12, 2025 at 10:35 am EDT - Marketscreener.com
Vivani Medical to Spin Off Cortigent Neurostim Biz - MPO-mag
EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value - AOL
Vivani Medical Plans to Spin Off Cortigent Neurostimulation Business -March 12, 2025 at 09:20 am EDT - Marketscreener.com
Vivani Medical intends to spin off Cortigent division - TipRanks
Vivani to spin off Cortigent as an independent entity - Investing.com India
Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business - Business Wire
Vivani to spin off neurostimulation business - Yahoo Finance
Lessons Learned From Vivani Medical's Study Of GLP-1 Implant - Clinical Leader
Vivani Medical’s chief business officer buys $1,110 in stock By Investing.com - Investing.com Australia
Vivani Medical’s chief business officer buys $1,110 in stock - Investing.com India
Second Sight Medical stock hits 52-week low at $1.1 amid challenges - Investing.com
Head to Head Review: Vivani Medical (NASDAQ:VANI) & BioLife Solutions (NASDAQ:BLFS) - Defense World
Comparing Precision Optics (NASDAQ:POCI) & Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now - GlobeNewswire Inc.
Geode Capital Management LLC Purchases 15,008 Shares of Vivani Medical, Inc. (NASDAQ:VANI) - Defense World
Reviewing CONMED (NYSE:CNMD) and Vivani Medical (NASDAQ:VANI) - Defense World
SABBY MANAGEMENT, LLC Acquires Additional Shares in Bluejay Diag - GuruFocus.com
Financial Contrast: Getinge AB (publ) (OTCMKTS:GNGBY) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani begins exenatide implant trial for obesity in Australia - Yahoo Finance
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia - AOL
Vivani Medical begins first human trial of implantable drug - Investing.com
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Business Wire
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 29.6% - MarketBeat
Financial Review: Vivani Medical (NASDAQ:VANI) vs. Heyu Biological Technology (OTCMKTS:HYBT) - Defense World
Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares - Simply Wall St
Vivani Medical: Q3 Earnings Snapshot - Darien Times
Vivani Medical Reports Q3 Loss, Advances GLP-1 Trials - TipRanks
Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares - MarketBeat
Vivani medical director Gregg Williams buys $5 million in stock By Investing.com - Investing.com Nigeria
Vivani medical director Gregg Williams buys $5 million in stock - Investing.com India
Vivani Medical Secures Funding for GLP-1 Implant Trial - TipRanks
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results - Business Wire
Vivani Medical (NASDAQ:VANI) Now Covered by HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Vivani Medical (VANI) with Buy Recommendation - MSN
3 US Penny Stocks To Monitor In October 2024 - Simply Wall St
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):